Question normal

Who are the other players on the value chain and what is their role?

Making a better Hep C drug (like Sovaldi) widely accessible would greatly benefit patients; however, in order to get a full understanding of the environment we are in, could you explain to us who the other players in the chain (hospitals, insurers, etc.) and what would be there cost or benefit?